Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network-Reference-Cited by-同舟云学术

Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network

Published:2022-01-13 Issue:7 Volume:128 Page:1439-1448
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Baldi Giacomo G.¹^ORCID,Lo Vullo Salvatore²^ORCID,Grignani Giovanni³^ORCID,Vincenzi Bruno⁴,Badalamenti Giuseppe⁵^ORCID,Mastore Marinella⁶,Buonomenna Ciriaco⁷,Morosi Carlo⁷,Barisella Marta⁸,Frezza Anna Maria⁹^ORCID,Provenzano Salvatore⁹,Simeone Noemi⁹,Picozzi Fernanda¹⁰¹¹,Mariani Luigi²,Casali Paolo G.⁹¹²,Stacchiotti Silvia⁹^ORCID

Affiliation:

1. Department of Medical Oncology Hospital of Prato Prato Italy

2. Unit of Clinical Epidemiology and Trial Organization Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

3. Division of Medical Oncology Candiolo Cancer Institute, FPO‐IRCCS Candiolo (TO) Italy

4. Department of Medical Oncology Campus Biomedico University of Rome Rome Italy

5. Department of Surgical, Oncological, and Oral Sciences ‐ Section of Medical Oncology University of Palermo Palermo Italy

6. Department of Medical Oncology San Gerardo Hospital Monza Italy

7. Department of Radiology Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

8. Department of Diagnostic Pathology and Laboratory Medicine Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

9. Department of Medical Oncology Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

10. Deparment of Medical Oncology Azienda Ospedaliera di Rilievo Nazionale dei Colli Monaldi‐Cotugno Naples Italy

11. Department of Electrical Engineering and Information Technology Federico II University of Naples Naples Italy

12. Department of Oncology and Hemato‐Oncology University of Milan Milan Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34083

Reference50 articles.

1. Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: Implications for disk degeneration and chordoma formation

2. Incidence and relative survival of chordomas

3. Chordomas and cartilaginous tumors at the skull base

4. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EP300 through upregulating the expression of vimentin to promote the progression of chordoma;Neurosurgical Focus;2024-05

2. Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics;Critical Reviews in Oncology/Hematology;2024-04

3. Radiotherapy After Gross Total Resection of Skull Base Chordoma: A Surveillance, Epidemiology, and End Results Database Analysis of Survival Outcomes;World Neurosurgery;2023-04

4. Targeted therapy, immunotherapy, and chemotherapy for chordoma;Current Medicine;2023-02-06

5. Impact of silencing eEF2K expression on the malignant properties of chordoma;Molecular Biology Reports;2023-01-18